Institute for Artificial Intelligence & Biomedical Research (AIBI) was initiated in 2021. Our goal is to build an integrated research platform namely “The Target Factory” to develop well-validated packages of targets and leads that can be used in biotech and pharmaceutical industry. We will do our best to establish AIBI the world’s first and best target factory that systematically translate original science and technology to new therapy and diagnosis for future medicine.

Sunghoon Kim Ph.D.

Director, Biocon / Professor, Yonsei University, Republic of Korea.

Development of New Drug Targets through High-Efficiency Bio-integrated research

An Integrated Research Platform for Novel Target and Lead Discovery